Home
Conditions
Leukemia, B-Cell

Clinical trial condition

Leukemia, B-Cell

Explore clinical trials studying Leukemia, B-Cell. Study availability and eligibility vary by location and protocol.

1,388 public trials 159 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, B-Cell trial results

Completed

Study of ABT-263 When Administered in Combination With Either Fludarabine/Cyclophosphamide/Rituximab or Bendamustine/Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia

NCT00868413

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: Site Reference ID/Investigator# 17841 La Jolla, California, United States

Site Reference ID/Investigator# 25899 Stanford, California, United States

Site Reference ID/Investigator# 21622 Baltimore, Maryland, United States

Site Reference ID/Investigator# 21621 Columbus, Ohio, United States

View Trial Details

Completed

Rituximab Plus Interleukin-2 in Treating Patients With Hematologic Cancer

NCT00010192

Conditions: B-cell Adult Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Chronic Disease, +82 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Pyroxamide in Treating Patients With Advanced Cancer

NCT00042900

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +90 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Alvocidib, Fludarabine Phosphate, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell Lymphoma

NCT00058227

Conditions: B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +71 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease

NCT00005613

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +29 more
Locations: Florida Cancer Specialists Fort Myers, Florida, United States

H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma

NCT00006373

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +29 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma, Acute Lymphoblastic Leukemia, or Acute Myeloid Leukemia

NCT00017472

Conditions: Chronic Disease, Disease Attributes, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, +34 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Green Tea Extract in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia

NCT00262743

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma

NCT00659568

Conditions: Adenocarcinoma, Blood Protein Disorders, Breast Cancer, +84 more
Locations: London Regional Cancer Program at London Health Sciences Centre London, Ontario, Canada

View Trial Details

Completed

Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer

NCT00045006

Conditions: Adenocarcinoma, Adnexal Diseases, Blood Protein Disorders, +110 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Leukemia, B-Cell

Leukemia, B-Cell trial results

Related conditions